GH1 and Freeman-Sheldon syndrome: Therefore, we expanded the number of children with FSS who were treated with GH that were examined in our pivotal study (1) to, first, confirm the results of the pivotal study concerning the proportion of monogenic etiology of FSS and its etiopathogenesis and, second, determine the clinical predictors for monogenic FSS.